| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $4,464,030 ) (Continued on the next page) |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 000 | 4 | NIH | 3/28/2024 | $166,277 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 000 | 8 | NIH | 12/21/2023 | $391,832 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 001 | 11 | NIH | 3/15/2024 | $373,451 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21CA286402 | Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors | 000 | 1 | NIH | 12/27/2023 | $223,377 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 1 | NIH | 4/1/2024 | $833,881 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P30HS029752 | Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) | 001 | 1 | AHRQ | 1/3/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P30HS029752 | Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) | 000 | 1 | AHRQ | 12/27/2023 | $984,408 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 001 | 1 | NIH | 4/3/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 000 | 1 | NIH | 3/28/2024 | $779,967 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 001 | 1 | NIH | 2/14/2024 | -$147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 001 | 1 | NIH | 2/14/2024 | $147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 000 | 1 | NIH | 1/22/2024 | $147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL168098 | Identification of a mechanosensor in juxtaglomerular cells for the regulation of renin synthesis and secretion | 000 | 1 | NIH | 1/8/2024 | $675,003 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL165097 | From Hypertensive Pregnancy to Heart Health: Understanding and Addressing Multi-Level Barriers to Cardiovascular Health after Hypertensive Disorders of Pregnancy | 000 | 1 | NIH | 2/2/2024 | $88,747 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL165097 | From Hypertensive Pregnancy to Heart Health: Understanding and Addressing Multi-Level Barriers to Cardiovascular Health after Hypertensive Disorders of Pregnancy | 000 | 1 | NIH | 2/2/2024 | $84,210 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an inherent bias in neuroprognostication: A collaboration between the US and Brazil to reduce the impact of Self-fulfilling Prophecy in cardiac ARrEst (SPARE) | 000 | 1 | NIH | 1/19/2024 | $782,427 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 001 | 1 | NIH | 4/1/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 1 | NIH | 12/29/2023 | $899,996 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | D3349076 | Preventive Medicine Residency | 00 | 2 | HRSA | 3/15/2024 | $147,368 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 003 | 3 | NIH | 3/13/2024 | $372,422 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH127308 | Adaptation and assessment of a common element treatment protocol designed to improve mental health in forcibly displaced populations | 000 | 3 | NIH | 3/15/2024 | $184,367 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 3 | NIH | 2/9/2024 | $189,431 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 4 | NIH | 3/29/2024 | $184,244 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 000 | 5 | NIH | 3/18/2024 | $185,132 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 000 | 4 | NIH | 2/21/2024 | $111,830 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T3210028 | NATIONAL RESEARCH SERVICE AWARD | 01 | 26 | HRSA | 12/15/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H1224845 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 11 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32HS022242 | Training in Health Services Research for Vulnerable Populations | 001 | 11 | AHRQ | 10/31/2023 | $127,262 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34MH134077 | Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial | 000 | 1 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34DA058124 | Sustaining recovery for people on opioid agonist treatment with conversational agents | 000 | 1 | NIH | 3/13/2024 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 01 | 1 | CDC | 11/28/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU58DP007538 | CHAMPS National | 01 | 1 | CDC | 11/13/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 01 | 2 | DHHS/OS | 12/5/2023 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 002 | 2 | NIH | 3/6/2024 | $74,974 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 001 | 2 | NIH | 1/17/2024 | $338,703 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08AI166125 | Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection | 001 | 2 | NIH | 1/4/2024 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9746074 | Special Projects of National Significance - Demonstration/Implementation Sites | 01 | 2 | HRSA | 1/11/2024 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 001 | 3 | SAMHSA | 3/26/2024 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 000 | 3 | SAMHSA | 2/14/2024 | $0 |
| | 2024 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 000 | 3 | NIH | 2/23/2024 | $0 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AG066892 | Improving Medical Decision Making for Older Patients with End Stage Renal Disease | 001 | 3 | NIH | 11/9/2023 | -$2,180,636 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH118373 | Reducing Duration of Untreated Psychosis through Motivational Interviewing for Loved Ones | 000 | 5 | NIH | 3/4/2024 | -$12,397 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R18HS026177 | Demonstrating, testing, and disseminating a sustainable model for academic detailing programs | 001 | 5 | AHRQ | 12/6/2023 | $96,350 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32HS022242 | Training in Health Services Research for Vulnerable Populations | 000 | 10 | AHRQ | 10/31/2023 | -$127,262 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 000 | 10 | NIH | 2/16/2024 | $0 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 01 | 2 | DHHS/OS | 12/5/2023 | $0 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R4145950 | Autism Secondary Data Analysis Research (SDAR) Program | 09 | 1 | HRSA | 2/8/2024 | -$36,641 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R4145950 | Autism Secondary Data Analysis Research (SDAR) Program | 08 | 1 | HRSA | 11/14/2023 | $0 |
| | 2024 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | S10OD032333 | Sartorious Octet R8 System | 000 | 1 | NIH | 2/14/2024 | $0 |
|
